Skip to main content
SpringerLink
Log in

Idiopathische Lungenfibrose

Tyrosinkinasehemmer bei IPF auch ohne UIP-Muster im Lungen-CT wirksam

  • journal club
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Raghu G et al. Am J Respir Crit Care Med. 2011;183:788–824.

    Article  PubMed  Google Scholar 

  2. Behr J, Günther A, Ammenwerth W et al. Pneumologie. 2013;67(2):81–111.

    Article  CAS  PubMed  Google Scholar 

  3. Richeldi L, du Bois RM, Raghu G et al. N Engl J Med. 2014;370:2071–82.

    Article  PubMed  Google Scholar 

  4. Behr J, Kreuter M, Hoeper MM et al. Eur Resp J. 2015;46:186–96.

    Article  Google Scholar 

  5. Lee JW, Shehu E, Gjonbrataj J et al. Resp Med. 2015;109:510–6.

    Article  Google Scholar 

Originalie

  • Raghu G, Wells AU, Nicholson AG et al. Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria. Am J Respir Crit Care Med. 2016 Jun 22. DOI: 10.1164/rccm.201602-0402OC

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik V, Pneumologie Herz-Thorax-Zentrum Fulda, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Deutschland

    Philipp Markart (Direktor, Stellvertretender Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“)

  2. Universitätsklinikum Giessen Marburg GmbH, Klinikstrasse 36, 35392, Giessen, Deutschland

    Philipp Markart (Direktor, Stellvertretender Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“) &  Andreas Günther (Chefarzt, Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“)

  3. AGAPLESION Pneumologische Klinik, Waldhof-Elgershausen, 35753, Greifenstein, Deutschland

    Andreas Günther (Chefarzt, Leiter Schwerpunkt: „Fibrosierende Lungenerkrankungen“)

Authors
  1. Philipp Markart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philipp Markart.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markart, P., Günther, A. Tyrosinkinasehemmer bei IPF auch ohne UIP-Muster im Lungen-CT wirksam. Pneumo News 8 (Suppl 7), 38–39 (2016). https://doi.org/10.1007/s15033-016-0486-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-016-0486-7

Search

Navigation